The Peripheral T-Cell Lymphomas

Claire DeardenDepartment of Haematology, The Royal Marsden NHS Foundation Trust, Sutton, UK

Anna DoderoFondazione IRCCS istituto Nazionale dei Tumori, Milano, Italy; and University of Milano, Italy

Jehan DupuisLymphoid Malignancies Unit, Henri Mondor University Hospital, Créteil, France

Karolina H. DziewulskaDepartment of Medicine and Department of Pathology, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA

Dima El‐SharkawiDepartment of Haematology, The Royal Marsden NHS Foundation Trust, Sutton, UK

Leonardo José Enciso‐OliveraPrograma de Investigación e Innovación en Leucemias Agudas y Crónicas (PILAC) Instituto Nacional de Cancerología, Bogotá, Colombia

Massimo FedericoDepartment of Surgical, Medical and Dental Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Reggio Emilia, Italy

David J. FeithDepartment of Medicine, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA

Andrew L. FeldmanDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

Francine FossDepartment of Hematology, Yale University School of Medicine, New Haven, CT, USA

Philippe GaulardAssistance Publique des Hôpitaux de Paris, Paris, France; Institut Mondor de Recherche Biomédicale, INSERMU955, Université Paris Est Créteil, Créteil, France; and Département de Pathologie, Hôpitaux Universitaires Henri Mondor, Créteil, France

Alejandro A. GruDepartment of Pathology and Dermatology, University of Virginia, Charlottesville, VA, USA

Sean HarropEpworth Healthcare and Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Keiichiro HattoriDepartment of Hematology, Faculty of Medicine, University of Tsukuba Hospital, Tsukuba, Japan

Eliza HawkeDepartment of Oncology and Clinical Haematology, Austin Health, Heidelberg, Victoria, Australia

Tyler A. HerekDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA

Henry Idrobo‐QuinteroGrupo Latinoamericano de estudio de Linfoproliferativos (GELL) Hospital Universitario del Valle, Grupo Ospedale, Universidad del Valle, Universidad Libre, Cali, Colombia.

Javeed IqbalDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA

Arnaud JaccardService d’Hématologie et de Thérapie Cellulaire, Hôpital Dupuytren, CHU de Limoges, Limoges, France

Elaine S. JaffeHematopathology Section, Laboratory of Pathology, Center for Cancer Research, NCI, Bethesda, MD, USA

Salvia JainDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA, and Harvard Medical School, Boston, MA, USA

Avyakta KallamDivision of Oncology‐Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA

Seok Jin KimDivision of Hematology and Oncology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea

Won Seog KimDivision of Hematology and Oncology,Sungkyunkwan University School of Medicine,Samsung Medical Center,Seoul, Korea

Raphael KochDepartment of Hematology and Medical Oncology, University Medical Center Goettingen, Goettingen, Germany

Jianping KongDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

Iryna KriachokOncohematology Department, National Cancer Institute, Kyiv, Ukraine

Manabu KusakabeDepartment of Hematology, Faculty of Medicine, University of Tsukuba Hospital, Tsukuba, Japan, and Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan

François LemonnierUnité hémopathies Lymphoïdes, Hôpitaux Universitaires Henri Mondor, Créteil, France; Assistance Publique des Hôpitaux de Paris, Paris, France; and Institut Mondor de Recherche Biomédicale, INSERMU955, Université Paris Est Créteil, Créteil, France

Soon Thye LimDivision of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore

Thomas P. Loughran, JrDepartment of Medicine, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA

Helen MaDepartment of Medicine, Division of Hematology and Oncology, Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY, USA

Martina ManniDepartment of Surgical, Medical and Dental Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Reggio Emilia, Italy

Enrica MarchiUniversity of Virginia Cancer Center, Charlottesville, VA, USA

Rolando Humberto Martinez‐CorderoInstituto Nacional de Cancerología, Universidad El Bosque, Bogotá, Colombia

Mwanasha MerrillDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA

Kevin MolloyDepartment of Dermatology, University Hospital, Birmingham, UK

Francesca MontanariCenter for Lymphoid Malignancies, Columbia University Medical Center, New York, NY, USA

Katharine B. MoosicDepartment of Medicine and Department of Pathology, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA

Franck MorschhauserDepartment of Hematology, Lille University Hospital, Lille, France

Wataru MunakataDepartment of Hematology, National Cancer Center Hospital, Tokyo, Japan

Owen A. O’ConnorDepartment of Medicine, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA, and Program for T‐Cell Lymphoma Research, Department of Microbiology, Immunology and Cancer Research University of Virginia Cancer Center, Charlottesville, VA, USA

Kristine C. OlsonDepartment of Medicine, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA

Juan Alejandro Ospina‐IdárragaLos Cobos Medical Center, Instituto Nacional de Cancerología, Universidad El Bosque, Bogotá, Colombia

Neval OzkayaHematopathology Section, Laboratory of Pathology, Center for Cancer Research, NCI, Bethesda, MD, USA

Pier Paolo PiccalugaDepartment of Experimental, Diagnostic, and Specialty Medicine, Bologna University School of Medicine, Bologna, Italy

Stefano A. PileriHematopathology Division, European Institute of Oncology, IRCCS, Milan, Italy

H. Miles PrinceEpworth Healthcare and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia

Barbara ProDivision of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA, and Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA

Dejan RadjeskiSir Charles Gardner Hospital, Perth, Western Australia, Australia

Bethanie RookeDepartment of Dermatology, University Hospital, Birmingham, UK

Tatsuhiro SakamotoDepartment of Hematology, Faculty of Medicine, University of Tsukuba Hospital, Tsukuba, Japan, and Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan